Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19487069rdf:typepubmed:Citationlld:pubmed
pubmed-article:19487069lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:19487069lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:19487069lifeskim:mentionsumls-concept:C0021083lld:lifeskim
pubmed-article:19487069lifeskim:mentionsumls-concept:C0544452lld:lifeskim
pubmed-article:19487069lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:19487069lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:19487069lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:19487069lifeskim:mentionsumls-concept:C0728938lld:lifeskim
pubmed-article:19487069lifeskim:mentionsumls-concept:C0205197lld:lifeskim
pubmed-article:19487069lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:19487069lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:19487069pubmed:issue7lld:pubmed
pubmed-article:19487069pubmed:dateCreated2009-6-22lld:pubmed
pubmed-article:19487069pubmed:abstractTextTo investigate post-transplant immunotherapy with escalating donor-lymphocyte infusions (DLI) and novel agents (thalidomide, bortezomib, and lenalidomide) to target complete remission (CR).lld:pubmed
pubmed-article:19487069pubmed:languageenglld:pubmed
pubmed-article:19487069pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19487069pubmed:citationSubsetIMlld:pubmed
pubmed-article:19487069pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19487069pubmed:statusMEDLINElld:pubmed
pubmed-article:19487069pubmed:monthJullld:pubmed
pubmed-article:19487069pubmed:issn1873-2399lld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:CorradiniPaol...lld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:NaglerArnonAlld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:ShimoniAvicha...lld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:KrögerNicolau...lld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:ZabelinaTatja...lld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:FehseBorisBlld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:AyukFrancisFlld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:AtanackovicDj...lld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:SchillingGeor...lld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:ZanderAxelAlld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:SchwarzSabine...lld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:LioznovMichae...lld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:BacherUlrikeUlld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:BadbaranAnita...lld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:KlyuchnikovEv...lld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:ZeschkeSilkeSlld:pubmed
pubmed-article:19487069pubmed:authorpubmed-author:HildebrandYor...lld:pubmed
pubmed-article:19487069pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19487069pubmed:volume37lld:pubmed
pubmed-article:19487069pubmed:ownerNLMlld:pubmed
pubmed-article:19487069pubmed:authorsCompleteYlld:pubmed
pubmed-article:19487069pubmed:pagination791-8lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:meshHeadingpubmed-meshheading:19487069...lld:pubmed
pubmed-article:19487069pubmed:year2009lld:pubmed
pubmed-article:19487069pubmed:articleTitlePost-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.lld:pubmed
pubmed-article:19487069pubmed:affiliationDepartment for Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. nkroeger@uke.uni-hamburg.delld:pubmed
pubmed-article:19487069pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19487069pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19487069lld:pubmed